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The effector repertoire of enteropathogenic E. coli: ganging up on
the host cell
Paul Dean and Brendan KennyDiarrhoeal disease caused by enteropathogenic E. coli (EPEC)
is dependent on a delivery system that injects numerous
bacterial ‘effector’ proteins directly into host cells. The best-
described EPEC effectors are encoded together on the locus of
enterocyte effacement (LEE) pathogenicity island and display
high levels of multifunctionality and cooperativity within the
host cell. More recently, effectors encoded outside the LEE
(non-LEE effectors) have been discovered and their functions
are beginning to be uncovered. The recent completion of the
EPEC genome sequence suggests its effector repertoire
consists of at least 21 effector proteins. Here, we describe the
genomic location of effectors and discuss recent advances
made on effector cellular function as well as their role in the
infection process.
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Introduction
Enteropathogenic E. coli (EPEC) is a human pathogen of
the small intestine that causes severe watery diarrhoea,
particularly among infants in developing countries [1].
EPEC is a member of a closely related family of patho-
gens that induce characteristic attaching and effacing (A/
E) lesions on intestinal epithelial cells in humans (EPEC
and EHEC — enterohaemorrhagic E. coli), ruminants
(EHEC) and small animals including mice (Citrobacter
rodentium) [2]. Hallmarks of EPEC disease are loss (effa-
cement) of absorptive microvilli, induction of actin-rich
pedestals underneath adherent bacteria, rapid watery
diarrhoea, inhibition of nutrient/water transporter func-
tion, mitochondrial dysfunction, a weak inflammatory
response and tight junction (TJ) disruption (see [1,3]).
Upon initial contact with intestinal enterocytes, mediated
Open access under CC BY license.www.sciencedirect.comin part by the bundle forming pilus (BFP), EPEC rapidly
cause the effacement of microvilli and induce localised
actin polymerisation that gives rise to a pedestal beneath
the bacteria, to which the bacteria intimately attach.
Mitochondrial dysfunction and disruption of nutrient
transporters are also early events, whilst the disruption
of TJ is only apparent later on during the infection
process. EPEC is considered a non-invasive pathogen
and relies upon on a type three secretion system
(T3SS) to deliver effector proteins directly into host cells
which subvert a myriad of host cellular functions, ulti-
mately leading to disease [3]. The first EPEC effectors to
be discovered are all encoded on a large genomic patho-
genicity island called the locus of enterocyte effacement
(LEE), which also carries EPEC’s only T3SS, with seven
LEE effectors identified to date. More recently, effectors
encoded outside the LEE region have been found in all
A/E pathogens [4,5] which utilise the LEE T3SS for
delivery into host cells and recent functional studies on
these ‘non-LEE’ effectors have started to ascribe cellular
functions to these proteins. The completion of the gen-
ome sequence of the prototypical EPEC strain E2348/69
(herein termed EPEC; www.sanger.ac.uk/Projects/
Escherichia_Shigella) has confirmed the presence (or
absence) of many non-LEE effector genes [6].
EPEC also possess a type two secretion system (T2SS),
although little is known about its role in virulence or its
protein substrates [6], and a type five secretion system
(T5SS) which includes the enterotoxin EspC and other
putative autotransporters [7,8]. Interestingly, the entry of
EspC into the host cells has been shown to be dependent
on T3SS [8] and it is likely that other autotransporters
may also depend on the T3SS. In this review we will focus
on the repertoire of type three secreted EPEC effector
proteins and the important advances made on effector
functions over the past few years. We redirect the reader
to other reviews for information on other virulence factors
and general mechanisms of EPEC pathogenesis [1,3,7].
EPEC effector nomenclature
The naming of EPEC effectors has been based on three
approaches and may be somewhat confusing to the lay
reader. Traditionally, the term ‘Esp-’ was used to denote
EPEC secreted protein and now includes the LEE effec-
tors EspB/F/G/H. However, EspA and EspD, which have
not been reported to possess effector activity, and the
autotransporter EspC, also fall into this category, making
effector designation a little ambiguous. A different
approach was to name effectors to reflect their reportedCurrent Opinion in Microbiology 2009, 12:101–109
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Table 1
The effector repertoire of EPEC 2348/69 and known functional characteristics of effector proteins.
EPEC
effector
Island
location
Cellular/physiological
functions
Subcellular target
sites
Proposed host
partners
Functional
motifs
Homologue family
Tir LEE Actin polymerisation Plasma membrane IQGAP1 SH3-binding
domains
None known
TJ disruptiona Cytoplasm 14-3-3tau GAP motif
Cell detachment Nck Phos. sites
Microvilli effacement a-Actinin
SGLT-1 inactivation Talin
PLCg phosphorylation Cortactin
Regulating effector activitya Vinculin
Invasion non-polarised cells Cytokeratin 18
Map LEE TJ disruption Mitochondria EBP50/ PDZ1-binding
domain
IpgB2
Filopodia formation Actina NHERF1 MTS
Mitochondrial dysfunction Cytoplasm WxxxE
Microvilli effacement
SGLT-1 inactivation
Invasion non-polarised cells
EspB LEE Anti-phagocytosis Cytoplasm Antitrypsin YopD
Microvilli effacement Plasma membrane a-Catenin
Actin disruption Myosin
Pore formation
EspF LEE Apoptosis Mitochondria, cytoplasm ABCF2 PRR, None known except
other EspF variants
such as EspF(U)
TJ disruption Apical and lateral
membranes
Actin SH3
Microvilli effacement TJ regiona ZO-1/ZO-2 N-WASP and SNX9
binding domains
Microvilli elongation Profilin MTS
SGLT-1 inactivation Arp2/3
Mitochondrial dysfunction Cytokeratin18
Pedestal maturation Sorting nexin 9
Inhibition of NHE3 activity N-WASP
Membrane remodelling 14-3-3
Aquaporin redistribution Mito proteinb
N-WASP activation
EspH LEE Modulating actin dynamics Pedestals None known
Cytoskeleton disruption Plasma membrane
EspZ LEE Unknown Pedestals None known
EspG LEE Microtubule disruption Microtubule
colocalisation
Tubulin VirA
TJ disruption
Paracellular permeability
Aquaporin redistribution
Stress fibres formation
DRA transporter inhibition
NleH1 PP2 Pro-inflammatory OspG
EspJ PP2 Anti-phagocytosis None known
NleB2 PP4 Unknown None known
NleC PP4 Unknown AIP56c
NleD PP4 Unknown HopAP1, HopH1d
NleG PP4 Unknown None
NleH2 PP6 Pro-inflammatory OspG
NleF PP6 Unknown None
NleA PP6 Inhibition of protein secretion
by interference
Golgi Sec24 PDZ1 None known
(EspI) with COPII PDZK11
SNX27
MAlS3
TCOF1b
Current Opinion in Microbiology 2009, 12:101–109 www.sciencedirect.com
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Table 1 (Continued )
EPEC
effector
Island
location
Cellular/physiological
functions
Subcellular target
sites
Proposed host
partners
Functional
motifs
Homologue family
NleE2 IE2 PMN transepithelial migration Nucleus OspZ
EspG2/Orf3 IE5 As with EspG VirA
NleB1 IE6 Unknown None known
NleE1 IE6 PMN trans-epithelial migration Nucleus OspZ
EspL2 IE6 Unknown OspDe
EspL1 IE2 Pseudogene (see Figure 3)
NleB3 IE2 Pseudogene (see Figure 3)
EspO PP6 Pseudogene (see Figure 3)
Cif PP2 Pseudogene (see Figure 3)
NleH3 PP4 Pseudogene (see Figure 3)
The predicted set of EPEC effectors comprises 21 full-length genes and at least 5 identified pseudogenes (i.e. genes truncated by stop codons,
missing start codons, containing frameshift mutations). Where more than one copy of an effector exists, genes are numbered in accordance with
sequence comparison to known EHEC homologues. For example, the full-length gene EspL is more similar to EHEC EspL2, whilst the EspL
pseudogene corresponds with EspL1 and is named accordingly. All effectors are found on the chromosome in pathogenicity islands specified in [6]
and illustrated in Figure 3. We have attempted to include all the known and documented effector functions and the known subcellular locations from
published sources. ‘Homologue family’ gives an example of a known homologue from an effector family; where indicated as ‘none known’ this does
not discount similarities with unassigned hypothetical proteins. Island location is illustrated in Figure 3 in accordance with [6]. All other references can
be found in the text or in [3]. Phos, phosphorylation; MTS, mitochondrial targeting sequence; PRR, proline-rich repeat; SH3, src homology domains;
PMN, polymorphonuclear; TJ, tight junction; IQGAP, IQ motif containing GTPase activating protein; EBP50/NHERF1, Na+/H+ exchanger regulating
factor 1; ezrin–radixin–moesin, ERM-binding phosphoprotein of 50 kDa.
a We have attempted to include all the known and documented effector functions and the known subcellular locations from unpublished sources.
b ‘Functional motifs’ and ‘proposed host partners’ correspond to those that have been proved to have functional significance, although in some
cases, data from yeast two-hybrid protein–protein interactions are included as in [49,50].
c Photobacterium virulence protein.
d Pseudomonas syringae effector proteins.
e Also has Shiglella enterotoxin homology.function, thus the LEE effectors Translocated Intimin
receptor (Tir) and Mitochondrial-associated protein
(Map) fall into this group. Finally, the term non-LEE
encoded (Nle-) was coined by Deng et al. following their
discovery of several non-LEE effectors in Citrobacter [4].
However, this designation has not been adopted for all non-
LEE effectors — such as the non-LEE located EspG2/
Orf3 [9], EspI/NleA [10], cycle inhibiting factor (Cif) [11]
and a set of recently discovered non-LEE effectors in
EHEC, which have all been given the prefix ‘Esp-’ [5],
of which EspJ and EspL are encoded in EPEC (Table 1).
The LEE effectors — highly interdependent
and multifunctional
Historically, the LEE effectors were the first to be
identified in EPEC and to date a total of seven LEE-
encoded proteins delivered into the host cell have been
discovered, namely Tir, Map, EspF, EspG, EspZ (pre-
viously SepZ), EspH and EspB (which is also a translo-
cator and essential for the delivery of effectors into the
host cell) (see Table 1 and [3]). Also present on the LEE
is the outer membrane protein Intimin which, whilst not
delivered into host cells, causes numerous host cell
responses directly through its bacterial-encoded receptor
Tir or through various host cell receptors [1,3]. All the
LEE effectors, except EspZ [12], have proven deleter-
ious effects on the host cell (Table 1 and see [3]) and it is
likely that EspZ has important effector functions as it is
delivered early in the infection process and at similarly
high levels as the essential virulence determinant, Tirwww.sciencedirect.com[13]. The importance of the LEE effectors in the disease
process is unclear but animal infections using Citrobacter
and EHEC (as EPEC lacks a suitable animal model)
indicate that Tir is essential, linked to its role in bacterial
attachment, whilst the other LEE effectors have a smaller
but additive contribution to virulence [2,10,14,15].
The functions of the LEE effectors are highly varied and
Table 1 gives an up-to-date and comprehensive list of
reported effector functions. An emerging theme for the
LEE effectors, consistent with findings in other T3SS-
pathogens, is their multiple and overlapping functions
(termed functional redundancy) and their interdepen-
dence and cooperativity in subverting host cell activities
(Table 1 and Figure 1). For example, Map and EspF
synergise [16] whilst EspG and EspG2 function redun-
dantly [17] in the disruption of epithelial TJ, with the
Map/EspF TJ-disrupting activity proven in vivo [14,18].
Tir is essential for actin-pedestal formation following
binding to Intimin but is also involved in TJ disruption,
independent and dependent of Intimin (Dean and
Kenny, unpublished). Tir also downregulates Map-
induced filopodia formation (see [3]) and coordinates with
EspF, Intimin and Map to cause microvilli effacement
[19]. Indeed, Knutton and colleagues have also reported
overlapping roles for LEE effectors in microvilli efface-
ment ex vivo, using human intestinal material [20]. In
addition, Map and EspF both target mitochondria to alter
organelle shape and cause dysfunction — an activity that
occurs in vivo and proven to be important in diseaseCurrent Opinion in Microbiology 2009, 12:101–109
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Figure 1
The complexity of EPEC effector function. The multifunctional and overlapping properties of the EPEC effectors are depicted here by grouping effector
functions together. Three effectors have anti-phagocytic activities (shown here using the phagocytic-like gut-associated antigen presenting M-cells)
whilst at least five effectors act on microvilli and four inhibit SGLT-1 and other transporter activity, four disrupt tight junctions and three are involved in
pedestal and filopodia formation. At least three Nle effectors are also involved in inflammatory pathways. Microtubule and Golgi/ER disruption appears
to be specific to EspG/Orf3 and NleA, respectively. Also shown are effectors which have known actin-modulating properties. TJ, tight junctions; MT,
microtubules; AqP, aquaporins; NHE3, sodium hydrogen exchanger; Cl/OH, Cl/OH transporter; SGLT-1, sodium glucose cotransporter-1; ER,
endoplasmic reticulum; MV, microvilli.[14,15]. Such effector cooperativity appears to be just the
‘tip of the iceberg’ as a systematic genetic study in which
the LEE effectors were deleted in many different com-
binations eludes to an unprecedented level of functional
cooperativity between effectors (Kenny et al., unpub-
lished). To this end, all the major reported hallmarks
of EPEC disease can be attributed to the cooperative
efforts of the LEE effectors (Figure 1).
In addition to their cooperative nature, the LEE effectors
are strikingly multifunctional (Table 1) binding a large
number of eukaryotic proteins and targeting various host
cell compartments (Table 1 and Figure 1). This is bestCurrent Opinion in Microbiology 2009, 12:101–109exemplified by EspF which localises to multiple cellular
compartments (including cytoplasm, mitochondria, apical
and lateral membranes) and interacts with at least 12
reported host proteins, with its delivery linked to mito-
chondrial dysfunction, microvilli effacement, TJ disrup-
tion, apoptosis, epithelial transporter inhibition, anti-
phagocytosis, membrane remodelling and actin-pedestal
maturation [15,16,18–22,26,51–53]. Like other LEE
effectors, the modular construction of EspF facilitates
its multifunctional behaviour (Figure 2), with specific
motifs inducing distinct cellular responses, such as an
N-terminal mitochondrial targeting sequence (MTS)
linked to mitochondria dysfunction and apoptosiswww.sciencedirect.com
Identity and function of EPEC effectors Dean and Kenny 105
Figure 2
The modular nature of multifunctional LEE effector proteins. Tir, Map and EspF are the best-studied EPEC effectors and have been implicated in
subverting multiple cellular processes. These proteins possess many eukaryotic-like motifs with many being assigned to elicit specific host cellular
responses. Only those motifs/domains with proven and documented functions within the host cell are shown whilst chaperone binding sites or the N-
terminal bacterial secretion and translocation signals are not shown. Other EPEC effectors are not shown because of the paucity of information
regarding their functional domains. See text for abbreviations.[15,21], whilst proline-rich repeats, that include src
homology 3 (SH3)-binding domains, recruit sorting nexin
9 (SNX9) causing membrane remodelling ([22]; Table 1
and Figure 2). EspF, like its EHEC homologues EspF
and EspFU/Tccp, recruits N-WASP (a key regulator of
actin polymerisation), with studies on EspFU revealing it
specifically activates N-WASP by mimicking an internal
regulatory element [23,24]. Finally, although EspF plays
an essential role in anti-phagocytosis, EspB–myosin inter-
action has recently been reported to inhibit both phago-
cytosis and microvilli effacement [25]. However, as both
of these bacterial processes can occur with EspB/EspF-
positive but not EspB-positive/EspF-negative strains
[19,26]; this suggests that EspB is neither solely respon-
sible nor sufficient.
Effector multifunctionality is further demonstrated by
Map and Tir which like EspF, possess motifs that med-www.sciencedirect.comiate a broad array of functions ([3]; Table 1 and Figure 2).
All of Tir’s reported activities depend on its extracellular
domain (Figure 2) binding to Intimin, following Tir
insertion into the host plasma membrane. Tir’s N-term-
inal and C-terminal domains remain intracellular and
interact with numerous signalling, adapter and cyto-
skeletal proteins with Tir function dependent on its
phosphorylation sites, a GTPase activating protein
(GAP)-like motif and a polyproline region (Figure 2)
[27–29]. Interestingly, although tyrosine phosphorylation
of Tir is essential for actin-pedestal formation in immor-
talised cell lines, human biopsy material has revealed that
this crucial event is independent of tyrosine phosphoryl-
ation ex vivo, suggesting care should be taken when using
cell lines to elucidate effector function [30]. Map on the
other hand is reported to mimic the active form of
Cdc42 — a small GTPase — to induce filopodia formation
[31], in contrast to an earlier report demonstrating a depen-Current Opinion in Microbiology 2009, 12:101–109
106 Host–microbe interactions: Bacteriadence on Cdc-42 itself [32]. The filopodia-inducing func-
tions of Map depend on an invariant WxxxE motif and a
C-terminal class 1 PDZ-binding domain that binds Ezrin-
binding protein 50 [31,33] to presumably direct or retainFigure 3
The six identified non-LEE effector encoding pathogenicity islands of EPEC
genome using over 400 known/predicted effector sequences. The identified
data (see text), from which the genomic island names were obtained. Only th
(graph above each island) are shown with most prophage-related genes surr
individual arrows which are drawn to scale within each island and colour cod
homologues in EHEC as explained in the legend to Table 1. Pseudogene ke
EPEC strain [48]; (b) NleH3; C-terminal truncated; (c) NleO; no start codon; (
Current Opinion in Microbiology 2009, 12:101–109Map to the plasma membrane. Whether or not Map is a
Cdc42 mimic is open to debate as other effectors of
the WxxxE family appear to require GTPases to elicit
their cellular responses [32,34] and the controversyE2348/69. Predicted effector genes were identified by mining the EPEC
effectors and genomic islands support the genome sequence published
ose genomic regions encoding the effectors and with low %GC content
ounding these regions omitted. Genes and strand direction are shown by
ed (see inset). Multiple copies of genes are numbered according to close
y: (a) Cif; C-terminally truncated protein not produced or secreted in this
d) EspL1; stop codon in middle of gene; (e) NleB3; N-terminal truncated.
www.sciencedirect.com
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quently discussed in a recent review which provides a
compelling argument to suggest these effectors may not
be GTPase mimics after all [34]. Finally, Map possesses
an N-terminal MTS and targets the mitochondria where it
is imported via the classical TOM/Hsp70 import system
and causes mitochondrial dysfunction [35] (see Figures 1
and 2).
EPEC non-LEE effectors and non-LEE
pathogenicity islands
Whilst mining the EHEC (O157:H7 Sakai strain) genome
sequence with over 200 known/predicted T3SS-depend-
ent effector proteins, Pallen and colleagues identified 49
putative effectors [5]. At least 39 of these predicted
proteins, of which many are homologues, were confirmed
as secreted effectors in EHEC and include NleA-H
(noting 12 NleG homologues) and newly described
EspJ-O, EspR and EspV-Y effectors [5]. The recent
completion of the EPEC genome sequence (strain
E2348/69) enabled a similar ‘effector mining’ approach
using an expanded list of over 400 known/predicted
effector sequences and identified only 21 putative effec-
tors (Dean and Kenny, unpublished; Table 1 and
Figure 3). Thus, as recently reported [6], EPEC appears
to have a much smaller non-LEE effector repertoire than
EHEC, encoding NleA-H (two homologues of B, E, H
and only 1 of NleG), EspJ and EspL2, Orf3 (EspG2;
which is the only EPEC effector so far identified that is
not present in EHEC) and pseudogenes for NleH, EspO,
NleB, EspL and Cif (Table 1 and Figure 3). Thus, whilst
the LEE effector repertoire is well conserved, the set of
non-LEE effectors is apparently flexible as EPEC strains
B171-8 and E22 (rabbit-EPEC) possess 28 and 40 effec-
tors, respectively, compared to 21 for the prototypical
strain [6].
The non-LEE effector genes are clustered in six patho-
genicity islands (Figure 3) scattered throughout the gen-
ome, usually with a low G + C% content in regions
corresponding to effector genes. Interestingly, the non-
LEE effector genes are surrounded by phage-related and/
or transposase-like genes implying that, like most patho-
genicity islands, they were acquired through horizontal
acquisition [6]. Whilst EPEC E2348/69 carries at least 21
effector-encoding genes, it is not known whether they are
all expressed but undoubtedly other effectors remain to
be identified. Indeed, there are many hypothetical genes
in the non-LEE islands that are likely candidates as
effectors because of their low %GC content and close
proximity to known effector genes (Figure 3).
Because of the more recent discovery of non-LEE effec-
tors, relatively little is known about their cellular function
(summarised in Table 1), but NleA is reported to inhibit
protein secretion [36], EspJ inhibits phagocytosis [37],
whilst NleE [38] and NleH [39] activate innate immunewww.sciencedirect.comresponses. Studies with the mouse model suggest that
EspJ, NleB, NleE, NleF and NleH play a role in colonisa-
tion and full virulence [40–43] whilst NleC and D have no
detectable function [40,41]. Although NleA (also called
EspI) was reported to be a key virulence factor [44],
another study using the same mouse model, reported that
it only contributes to full virulence — as with most other
effectors [10]. Interestingly, despite NleE and NleH
reportedly inducing innate immune responses, EPEC
T3SS-dependent function has been demonstrated to inhi-
bit, not activate, such responses in small intestinal cells and
mouse studies [45,46]. Importantly, the reported inhibi-
tory mechanism was not dependent on LEE effectors,
implicating non-LEE effectors in the process [45]
although a LEE effector was recently identified that
inhibits NF-kB activation (Kenny et al., unpub-
lished) — revealing yet another overlapping role for
LEE and non-LEE effectors. Therefore, a discrepancy
exists as NleE and NleH appear to induce inflammatory
responses, whilst EPEC’s overall effect on host/host cells is
anti-inflammatory. It is possible that EPEC transiently
induces pro-inflammatory responses but rapidly inactivates
this response mechanism before the disruption of TJs, that
is associated with onset of inflammatory cascades [45].
Thus, like the activities of many other EPEC effectors, a
delicate balance likely exists between pro-inflammatory
and anti-inflammatory signalling mechanisms [47].
Conclusions
‘Multifunctional, cooperative and redundant’ are three
overriding themes that describe EPEC effector beha-
viour and are becoming increasingly accepted for various
T3SS-pathogen effectors. Interestingly, the LEE effec-
tors appear to subvert many ‘core’ epithelial cell pro-
cesses and consequently, all of the major EPEC disease-
related hallmarks have been attributed to the LEE
effectors, suggesting the non-LEE effectors may func-
tion mainly as accessory/efficiency factors. However, it is
worth pointing out that individual non-LEE effectors are
more highly conserved between A/E pathogens than
LEE effectors [6], possibly reflecting the targeting of
well conserved processes, whilst LEE-effector variabil-
ity may reflect different host ranges. The high level of
functional interdependence between the LEE effectors
possibly reflects their continued co-evolution within the
LEE pathogenicity island and this sets an exciting pre-
cedent that other effectors co-inherited together may
display similarly complex levels of interplay. A future
challenge will be to define the contribution of all effec-
tors in each disease process by identifying the effector
domains and motifs responsible. Only then the contri-
bution of the particular effector function to the disease
process can be assessed in animal models. Nonetheless
the expanded repertoire of effectors provides fascinating
opportunities to understand how pathogens subvert cel-
lular processes and increase our understanding of vital
eukaryotic processes.Current Opinion in Microbiology 2009, 12:101–109
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